These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

707 related articles for article (PubMed ID: 27694909)

  • 1. Inhibitory effects of hesperetin on Nav1.5 channels stably expressed in HEK 293 cells and on the voltage-gated cardiac sodium current in human atrial myocytes.
    Wang H; Wang HF; Zhang H; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Acta Pharmacol Sin; 2016 Dec; 37(12):1563-1573. PubMed ID: 27694909
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inhibitory effects of hesperetin on Kv1.5 potassium channels stably expressed in HEK 293 cells and ultra-rapid delayed rectifier K(+) current in human atrial myocytes.
    Wang H; Wang HF; Wang C; Chen YF; Ma R; Xiang JZ; Du XL; Tang Q
    Eur J Pharmacol; 2016 Oct; 789():98-108. PubMed ID: 27397430
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tetrodotoxin-sensitive α-subunits of voltage-gated sodium channels are relevant for inhibition of cardiac sodium currents by local anesthetics.
    Stoetzer C; Doll T; Stueber T; Herzog C; Echtermeyer F; Greulich F; Rudat C; Kispert A; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Jun; 389(6):625-36. PubMed ID: 27000037
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of A-803467 on cardiac Nav1.5 channels.
    Han Z; Jiang Y; Xiao F; Cao K; Wang DW
    Eur J Pharmacol; 2015 May; 754():52-60. PubMed ID: 25701724
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distinctive property and pharmacology of voltage-gated sodium current in rat atrial vs ventricular myocytes.
    Chen KH; Xu XH; Sun HY; Du XL; Liu H; Yang L; Xiao GS; Wang Y; Jin MW; Li GR
    Heart Rhythm; 2016 Mar; 13(3):762-70. PubMed ID: 26598320
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Azithromycin Causes a Novel Proarrhythmic Syndrome.
    Yang Z; Prinsen JK; Bersell KR; Shen W; Yermalitskaya L; Sidorova T; Luis PB; Hall L; Zhang W; Du L; Milne G; Tucker P; George AL; Campbell CM; Pickett RA; Shaffer CM; Chopra N; Yang T; Knollmann BC; Roden DM; Murray KT
    Circ Arrhythm Electrophysiol; 2017 Apr; 10(4):. PubMed ID: 28408648
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inhibition of the cardiac Na⁺ channel α-subunit Nav1.5 by propofol and dexmedetomidine.
    Stoetzer C; Reuter S; Doll T; Foadi N; Wegner F; Leffler A
    Naunyn Schmiedebergs Arch Pharmacol; 2016 Mar; 389(3):315-25. PubMed ID: 26667357
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of 4,9-anhydrotetrodotoxin on voltage-gated Na
    Takahara K; Yamamoto T; Uchida K; Zhu HL; Shibata A; Inai T; Noguchi M; Yotsu-Yamashita M; Teramoto N
    Naunyn Schmiedebergs Arch Pharmacol; 2018 May; 391(5):489-499. PubMed ID: 29453527
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Biophysical comparison of sodium currents in native cardiac myocytes and human induced pluripotent stem cell-derived cardiomyocytes.
    Goodrow RJ; Desai S; Treat JA; Panama BK; Desai M; Nesterenko VV; Cordeiro JM
    J Pharmacol Toxicol Methods; 2018; 90():19-30. PubMed ID: 29128504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibitory effects of neferine on Nav1.5 channels expressed in HEK293 cells.
    Wang C; Wang H; Xiao JH; Wang JL; Xiang JZ; Tang Q
    J Huazhong Univ Sci Technolog Med Sci; 2016 Aug; 36(4):487-493. PubMed ID: 27465321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lateral Membrane-Specific MAGUK CASK Down-Regulates NaV1.5 Channel in Cardiac Myocytes.
    Eichel CA; Beuriot A; Chevalier MY; Rougier JS; Louault F; Dilanian G; Amour J; Coulombe A; Abriel H; Hatem SN; Balse E
    Circ Res; 2016 Aug; 119(4):544-56. PubMed ID: 27364017
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cardiotoxic Antiemetics Metoclopramide and Domperidone Block Cardiac Voltage-Gated Na+ Channels.
    Stoetzer C; Voelker M; Doll T; Heineke J; Wegner F; Leffler A
    Anesth Analg; 2017 Jan; 124(1):52-60. PubMed ID: 27861438
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Disruption of asparagine-linked glycosylation to rescue and alter gating of the Na
    Wang P; Zhu X; Wei M; Liu Y; Yoshimura K; Zheng M; Liu G; Kume S; Kurokawa T; Ono K
    Heart Vessels; 2021 Apr; 36(4):589-596. PubMed ID: 33392644
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antidepressants inhibit Na
    Horishita T; Yanagihara N; Ueno S; Okura D; Horishita R; Minami T; Ogata Y; Sudo Y; Uezono Y; Sata T; Kawasaki T
    Naunyn Schmiedebergs Arch Pharmacol; 2017 Dec; 390(12):1255-1270. PubMed ID: 28905186
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distribution and function of sodium channel subtypes in human atrial myocardium.
    Kaufmann SG; Westenbroek RE; Maass AH; Lange V; Renner A; Wischmeyer E; Bonz A; Muck J; Ertl G; Catterall WA; Scheuer T; Maier SKG
    J Mol Cell Cardiol; 2013 Aug; 61():133-141. PubMed ID: 23702286
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The cardiac sodium current Na(v)1.5 is functionally expressed in rabbit bronchial smooth muscle cells.
    Bradley E; Webb TI; Hollywood MA; Sergeant GP; McHale NG; Thornbury KD
    Am J Physiol Cell Physiol; 2013 Aug; 305(4):C427-35. PubMed ID: 23784541
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differential inhibition of cardiac and neuronal Na(+) channels by the selective serotonin-norepinephrine reuptake inhibitors duloxetine and venlafaxine.
    Stoetzer C; Papenberg B; Doll T; Völker M; Heineke J; Stoetzer M; Wegner F; Leffler A
    Eur J Pharmacol; 2016 Jul; 783():1-10. PubMed ID: 27130441
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMOylation of the cardiac sodium channel Na
    Yoon JY; Greiner AM; Jacobs JS; Kim YR; Rasmussen TP; Kutschke WJ; Matasic DS; Vikram A; Gaddam RR; Mehdi H; Irani K; London B
    Heart Rhythm; 2023 Nov; 20(11):1548-1557. PubMed ID: 37543305
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Exenatide reduces atrial fibrillation susceptibility by inhibiting hKv1.5 and hNav1.5 channels.
    Zhou Q; Hao G; Xie W; Chen B; Lu W; Wang G; Zhong R; Chen J; Ye J; Shen J; Cao P
    J Biol Chem; 2024 May; 300(5):107294. PubMed ID: 38636665
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The citrus flavanone hesperetin preferentially inhibits slow-inactivating currents of a long QT syndrome type 3 syndrome Na
    Alvarez-Collazo J; López-Requena A; Galán L; Talavera A; Alvarez JL; Talavera K
    Br J Pharmacol; 2019 Apr; 176(8):1090-1105. PubMed ID: 30650182
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 36.